Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Whitehurst represents UNC Lineberger at SU2C telecast
Dr. Angelique Whitehurst, assistant professor of pharmacology, was awarded a 2011 Innovative Research Grant from Stand Up to Cancer, the scientific partner of the American Association of Cancer Research.
Located in News / 2012 News
TCGA discovers potential therapeutic targets for lung squamous cell carcinoma
Changes in DNA that are important to the initiation and progression of lung cancer also identified by NIH-supported researchers
Located in News / 2012 News
Rathmell, Yang honored with Hettleman awards
Located in News / 2012 News
UNC women's basketball team brings smiles to N.C. Cancer Hospital
Located in News / 2012 News
Cancer survivor Wanda Wooten shares her story
Wanda Wooten talks with NBC 17 about the day she was diagnosed with ovarian cancer and her treatment and offers encouragement to other women facing ovarian cancer.
Located in News / 2012 News
ENCODE scientists show how DNA blueprint functions
UNC scientists were co-principal investigators and collaborators for projects described in the September 6, 2012 special issue of the journal Nature describing the ENCODE (Encyclopedia of DNA Elements) Project.
Located in News / 2012 News
UNC headlines American Cancer Society breakfast
UNC Head Basketball Coach Roy Williams and UNC Lineberger physician-scientist Kim Rathmell, MD, PhD, were featured speakers at the American Cancer Society’s Cancer Action Network breakfast, held August 24th in Research Triangle Park.
Located in News / 2012 News
Program offers outdoor adventures to cancer survivors, UNC faculty volunteer services
Kayaking and rock climbing aren’t usual clinical activities for UNC Lineberger medical oncologist Dr. Juneko Grilley-Olson and nurse practitioner Elizabeth Sherwood, but they were during the time that each volunteered for a First Descents camp week for young adult cancer survivors.
Located in News / 2012 News
Jobin discusses recent study in Nature, Scientific American
Located in News / 2012 News
Study reveals new molecular target for melanoma treatment
Chapel Hill, NC – A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood.
Located in News / 2012 News